Gastrointestinal bleeding: From conventional to nonconventional!

Endoscopy

Volumn 40, Issue 1, 2008, Pages 40-44

  Rana, S S ^a   Bhasin, Deepak K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CONTRAST MEDIUM; CYANOACRYLATE; HISTAMINE H2 RECEPTOR ANTAGONIST; IODINATED POPPYSEED OIL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; VASOACTIVE AGENT;

ABSENCE OF SIDE EFFECTS; ACUTE HEART INFARCTION; ARTICLE; BALLOON OCCLUSION; BLOOD TRANSFUSION; CAPSULE ENDOSCOPY; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CONTROL; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCARDIOGRAPHY; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; FLUOROSCOPY; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HEMOSTASIS; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; HYPOTENSION; HYPOXEMIA; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PEPTIC ULCER BLEEDING; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RESPIRATORY ARREST; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SECONDARY PREVENTION; STENT; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT; UPPER GASTROINTESTINAL BLEEDING; VASCULAR SURGERY; VEIN LIGATION;

ANGIOGRAPHY; CAPSULE ENDOSCOPY; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 38849183341     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995320     Document Type: Article

References (17)

1. Hubmann R, Bodlaj G, Czompo M et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 2006; 38: 896-901
2. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126: 1175-1189
3. Lo GH, Liang HL, Chen WC et al. A prospective, randomized controlled trait of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39: 679-685
4. Noh DY, Park SY, Joo SY et al. Therapeutic effect of the endoscopic N-butyl-2-cyanoacrylate injection for acute esophagogastric variceal bleeding: comparison with transjugular intrahepatic portosystemic shunt. Korean J Gastroenterol 2004: 43: 186-195
5. Mahadeva S, Bellamy MC Kessel D et al. Cost-effectiveness of n-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol 2003; 98: 2688-2693
6. Triester SL, Leighton JA, Leontiadis GI et al. A meta analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with OGIB. Am J Gastroenterol 2005; 100: 2407-2418
7. Saperas E, Dot J, Videla S et al. Capsule endoscopy versus computed tomographic or standard angiography for the diagnosis of obscure gastrointestinal bleeding. Am J Gastroenterol 2007; 102: 731-737
8. Neu B, Ell C, May A et al. Capsule endoscopy versus standard tests in influencing management of obscure digestive bleeding: results from a German multicenter trial. Am J Gastroenterol 2005: 100: 1736-1742
9. Bardou M, Toubouti Y, Benhaberou-Brun D et al. Meta-analysis: proton pump inhibition in high risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther 2005: 21: 677-686
10. Lau JY, Leung WK, Wu JCY et al. Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 2007; 356: 1631-1640
11. Keyvani L, Murthy S, Leeson S, Targownik LE. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding. Aliment Pharmacol Ther 2006; 24: 1247-1255
12. Andrews CN, Levy A, Fishman M et al. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study. Can J Gastroenterol 2005; 19: 667-671
13. Dorward S, Sreedharan A, Leontiadis GI et al. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 2006; 4: CD005415
14. Lin S, Konstance R, Jollis J, Fisher DA. The utility of upper endoscopy in patients with concomitant upper gastrointestinal bleeding and acute myocardial infarction. Dig Dis Sci 2006; 51: 2377-2383
15. Lee CT, Huang SP, Cheng TY et al. Factors associated with myocardial infarction after emergency endoscopy for upper gastrointestinal bleeding in high-risk patients: a prospective observational study. Am J Emerg Med 2007; 25: 49-52
16. Cappell MS, Iacovone FM Jr. Safety and efficacy of esophagogastroduodenoscopy after myocardial infarction. Am J Med 1999: 106: 29-35
17. Chen CC, Chong CF, Kuo CD, Wang TI. Silent myocardial ischemia in coronary artery disease patients under aspirin therapy presenting with upper gastrointestinal hemorrhage. J Gastroenterol Hepatol 2007: 22: 13-17